metyrapone has been researched along with Apnea, Sleep in 1 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Lind van Wijngaarden, RF | 1 |
| Joosten, KF | 1 |
| van den Berg, S | 1 |
| Otten, BJ | 1 |
| de Jong, FH | 1 |
| Sweep, CG | 1 |
| de Weerd, AW | 1 |
| Hokken-Koelega, AC | 1 |
1 trial available for metyrapone and Apnea, Sleep
| Article | Year |
|---|---|
The relationship between central adrenal insufficiency and sleep-related breathing disorders in children with Prader-Willi syndrome.
Topics: Adrenal Insufficiency; Child; Child, Preschool; Diagnostic Techniques, Endocrine; Female; Humans; Ma | 2009 |